| http://dbpedia.org/ontology/abstract
|
Apotex Inc v Sanofi-Synthelabo Canada Inc, … Apotex Inc v Sanofi-Synthelabo Canada Inc, [2008] 3 S.C.R. 265, is a leading Supreme Court of Canada decision on the novelty and non-obviousness requirements for a patent in Canada. The Court rejected a challenge by the generic drug manufacturer Apotex to declare Synthelabo Canada's patent for Plavix, an anti-coagulant drug, invalid. At issue was whether selection patents are invalid in principle, and if they are not, whether the subject selection patent was invalid on the grounds of anticipation, obviousness or double patenting.cipation, obviousness or double patenting.
|
| http://dbpedia.org/ontology/wikiPageExternalLink
|
https://web.archive.org/web/20130107040324/http:/www.ic.gc.ca/eic/site/cipointernet-internetopic.nsf/eng/h_wr02152.html +
, http://patents.ic.gc.ca/cipo/cpd/en/patent/1336777/summary.html%23 +
, https://wayback.archive-it.org/all/20120505103903/http:/brevets-patents.ic.gc.ca/opic-cipo/cpd/eng/patent/1194875/summary.html +
|
| http://dbpedia.org/ontology/wikiPageID
|
34176378
|
| http://dbpedia.org/ontology/wikiPageLength
|
8651
|
| http://dbpedia.org/ontology/wikiPageRevisionID
|
1122827750
|
| http://dbpedia.org/ontology/wikiPageWikiLink
|
http://dbpedia.org/resource/Category:Sanofi +
, http://dbpedia.org/resource/Novelty_and_non-obviousness_in_Canadian_patent_law +
, http://dbpedia.org/resource/Apotex +
, http://dbpedia.org/resource/Novelty_%28patent%29 +
, http://dbpedia.org/resource/Sanofi +
, http://dbpedia.org/resource/Patent +
, http://dbpedia.org/resource/Plavix +
, http://dbpedia.org/resource/Category:Canadian_intellectual_property_law +
, http://dbpedia.org/resource/Category:2008_in_Canadian_case_law +
, http://dbpedia.org/resource/Category:Canadian_patent_case_law +
, http://dbpedia.org/resource/Supreme_Court_of_Canada +
, http://dbpedia.org/resource/Category:Supreme_Court_of_Canada_cases +
, http://dbpedia.org/resource/List_of_Supreme_Court_of_Canada_cases_%28McLachlin_Court%29 +
, http://dbpedia.org/resource/Patent_Act_%28Canada%29 +
, http://dbpedia.org/resource/Federal_Court_of_Appeal +
, http://dbpedia.org/resource/Selection_patents +
|
| http://dbpedia.org/property/bot
|
InternetArchiveBot
|
| http://dbpedia.org/property/caseName
|
Apotex Inc v Sanofi-Synthelabo Canada Inc
|
| http://dbpedia.org/property/citations
|
2008
|
| http://dbpedia.org/property/date
|
October 2016
|
| http://dbpedia.org/property/decidedDate
|
"2008-11-06"^^xsd:date
|
| http://dbpedia.org/property/docket
|
31881
|
| http://dbpedia.org/property/fixAttempted
|
yes
|
| http://dbpedia.org/property/fullCaseName
|
Sanofi‑Synthelabo Canada Inc., Sanofi‑Synthelabo and Minister of Health
|
| http://dbpedia.org/property/heardDate
|
"2008-04-16"^^xsd:date
|
| http://dbpedia.org/property/history
|
Judgment against Apotex in the Federal Court of Appeal.
|
| http://dbpedia.org/property/notparticipating
|
McLachlin C.J.
|
| http://dbpedia.org/property/ratio
|
Selection patents are not invalid under the Patent Act.
|
| http://dbpedia.org/property/ruling
|
Appeal dismissed
|
| http://dbpedia.org/property/scc
|
2006
|
| http://dbpedia.org/property/unanimous
|
Rothstein J.
|
| http://dbpedia.org/property/wikiPageUsesTemplate
|
http://dbpedia.org/resource/Template:Dead_link +
, http://dbpedia.org/resource/Template:Lexum-scc +
, http://dbpedia.org/resource/Template:Reflist +
, http://dbpedia.org/resource/Template:SCCInfoBox +
|
| http://purl.org/dc/terms/subject
|
http://dbpedia.org/resource/Category:Supreme_Court_of_Canada_cases +
, http://dbpedia.org/resource/Category:2008_in_Canadian_case_law +
, http://dbpedia.org/resource/Category:Canadian_patent_case_law +
, http://dbpedia.org/resource/Category:Sanofi +
, http://dbpedia.org/resource/Category:Canadian_intellectual_property_law +
|
| http://purl.org/linguistics/gold/hypernym
|
http://dbpedia.org/resource/Court +
|
| http://www.w3.org/ns/prov#wasDerivedFrom
|
http://en.wikipedia.org/wiki/Apotex_Inc_v_Sanofi-Synthelabo_Canada_Inc?oldid=1122827750&ns=0 +
|
| http://xmlns.com/foaf/0.1/isPrimaryTopicOf
|
http://en.wikipedia.org/wiki/Apotex_Inc_v_Sanofi-Synthelabo_Canada_Inc +
|
| owl:sameAs |
http://www.wikidata.org/entity/Q4780733 +
, https://global.dbpedia.org/id/4RBf9 +
, http://dbpedia.org/resource/Apotex_Inc_v_Sanofi-Synthelabo_Canada_Inc +
, http://rdf.freebase.com/ns/m.0hr4_v8 +
|
| rdf:type |
http://dbpedia.org/ontology/Place +
|
| rdfs:comment |
Apotex Inc v Sanofi-Synthelabo Canada Inc, … Apotex Inc v Sanofi-Synthelabo Canada Inc, [2008] 3 S.C.R. 265, is a leading Supreme Court of Canada decision on the novelty and non-obviousness requirements for a patent in Canada. The Court rejected a challenge by the generic drug manufacturer Apotex to declare Synthelabo Canada's patent for Plavix, an anti-coagulant drug, invalid. At issue was whether selection patents are invalid in principle, and if they are not, whether the subject selection patent was invalid on the grounds of anticipation, obviousness or double patenting.cipation, obviousness or double patenting.
|
| rdfs:label |
Apotex Inc v Sanofi-Synthelabo Canada Inc
|
